市场调查报告书
商品编码
1466085
智慧医疗产品市场:按产品类型、应用、分布、最终用户划分 - 全球预测 2024-2030Smart Healthcare Products Market by Product Type (Electronic Health Record, mHealth, Smart Pills), Application (Health Data Storage and Exchange, Inventory Management, Monitoring and Treatment), Distribution, End-User - Global Forecast 2024-2030 |
※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。
预计2023年智慧医疗产品市场规模为76.9亿美元,预计2024年将达89.2亿美元,2030年将达到219.1亿美元,复合年增长率为16.11%。
智慧医疗保健产品市场包括各种旨在改善患者照护、简化医疗保健服务和优化医疗保健提供者业务成果的产品。该市场包括穿戴式装置、电子健康记录、智慧药丸、远端医疗解决方案等。智慧医疗产品的应用涵盖了健康管理的各个方面,包括诊断、监测、治疗、健康教育、健康预防等。最终用户范围从医院和诊所到寻求个人健康管理解决方案的个人消费者。这种多样化的应用基础凸显了这个市场的广度。推动智慧医疗产品市场扩张的关键因素是慢性病盛行率上升、人口老化、慢性病盛行率上升、智慧型手机普及上升以及个人化和高效的医疗保健解决方案的需求。然而,智慧医疗产品也存在一些局限性,例如高成本、资料隐私和安全问题以及缺乏跨平台和设备的标准化。监管挑战和某些地区技术采用缓慢也阻碍了成长。同时,政府加强对医疗基础设施数位化的支持,引进先进和创新的智慧医疗产品,创建可无缝整合到现有医疗保健系统的互通性和扩充性的解决方案,提供即时健康监测和服务。
主要市场统计 | |
---|---|
基准年[2023] | 76.9亿美元 |
预测年份 [2024] | 89.2亿美元 |
预测年份 [2030] | 219.1亿美元 |
复合年增长率(%) | 16.11% |
产品类型 人们越来越偏好用于个人健康追踪的行动医疗(行动医疗 ) 产品
电子健康记录(EHR) 系统是病患纸本病历的数位版本,可以即时存取。 EHR 记录患者的病历、诊断、治疗计划、药物、疫苗接种日期、过敏、放射影像、实验室检查结果等。电子病历受到医疗保健提供者的青睐,因为它们可以实现高效、无错误的记录并轻鬆存取患者资料,从而促进更好的决策。行动医疗(行动医疗) 涉及使用行动装置追踪健康参数、疾病管理和获取医疗保健服务。 行动医疗非常适合需要持续监测的患者、具有健康意识的患者以及需要远端医疗医疗咨询的患者。智慧药丸是带有电子元件的可摄入胶囊,可监测健康指标或以受控方式输送药物。适合需要严格用药依从性或正在接受需要密切监测的复杂治疗的患者。智慧 RFID 柜用于安全储存和管理医疗机构中的药品和用品,自动追踪存量基准和使用情况。对于需要简化库存管理、减少窃盗并确保药品安全的医院和药局至关重要。智慧注射器旨在防止重复使用,使用一次后自动停用,并采用针头缩回技术以避免针刺伤害。它们对于防止医疗机构中因共用针头和意外针刺而导致的感染疾病传播具有重要意义。远端医疗允许患者透过数位平台远端接受医疗服务,包括视讯通话。远端医疗对于偏远或服务欠缺地区的患者、行动不便的患者以及希望方便地获得专科护理的个人来说是有益的。智慧医疗产品市场多元化,每个细分市场都满足独特的医疗需求。电子病历和远端医疗的重点是资料存取和远端医疗提供,这在大流行期间和之后都至关重要。行动医疗提供个人健康跟踪,智慧药丸和智慧注射器专注于药物和治疗的准确性。
最终用户:医院扩大智慧医疗产品的使用,以改善病患的治疗效果
医院是智慧医疗产品的主要用户,专注于改善患者治疗结果、简化业务并做出资料主导的决策。受欢迎的医院产品包括人工智慧诊断和治疗系统、电子健康记录(EHR)、智慧床和病患监护系统。医院在这些创新中寻求的重点是互通性、扩充性以及与现有医院管理系统整合的能力。门诊护理病房 (ACU) 越来越多地采用智慧医疗产品,以提高患者照护和业务效率。在此类病房中,由于空间和移动性要求有限,因此首选紧凑、便携式且易于使用的设备。 ACU 对远端医疗平台、可携式监测设备和穿戴式健康设备的需求很高,以促进远端患者监护和即时健康追踪。在居家照护环境中,人们越来越偏好智慧医疗保健产品来支持居家照护和管理慢性病。促进远端健康监测、药物管理和紧急通知系统的设备尤其受到青睐。该细分市场的消费者优先考虑易用性、可靠性以及与其他智慧家庭设备整合的能力。在比较 ACU、家庭护理环境和医院中智慧医疗产品的使用情况时,出现了几个重要的差异。在 ACU 和家庭护理环境中,便携性和易用性是首要考虑因素,重点是远端监控功能,以支援传统临床环境之外的患者。相反,医院正在强调先进的互通性、资料分析和人工智慧主导的技术,以更大规模地提高患者照护和医院效率。
区域洞察
在美国和加拿大,人们越来越重视医疗保健效率和以病人为中心的照护。物联网 (IoT) 在健康设备中的整合、人工智慧 (AI) 以及主要市场参与者的存在正在对消费者的需求和购买产生重大影响。慢性病管理和远端患者监护是高度优先领域,导致智慧健康穿戴式装置和远端医疗解决方案的采用。由于人们对数位医疗技术和远端医疗优势的了解不断加深,南美地区,尤其是巴西等国家,智慧医疗产品的采用率不断增加。欧洲、中东和非洲地区情况各异,客户需求和购买行为各不相同。在欧盟国家,重点是数位健康集成,以遵循通用资料保护规范 (GDPR) 等法律规范,在数位健康解决方案中提供资料隐私。中东地区人口年轻,在大量投资和政府支持下热衷于采用创新医疗技术。儘管基础设施存在挑战,但行动医疗解决方案在非洲仍有潜力,这主要是由于行动普及较高,而且消费者的需求旨在解决医疗服务问题和管理感染疾病。由于亚太地区庞大的人口基数、可支配收入的增加以及对电子医疗潜力的认识不断增强,预计亚太地区将成为智慧医疗产品的高成长市场。拥有先进技术行业的日本和拥有大型製造业并正在医疗保健领域实施数位技术的中国等国家为这一增长做出了重大贡献。印度市场正在快速成长,在数位印度计画等措施的推动下,重点关注负担得起且易于获得的医疗保健解决方案。
FPNV定位矩阵
FPNV定位矩阵对于评估智慧医疗产品市场至关重要。我们检视与业务策略和产品满意度相关的关键指标,以对供应商进行全面评估。这种深入的分析使用户能够根据自己的要求做出明智的决策。根据评估,供应商被分为四个成功程度不同的像限:前沿(F)、探路者(P)、利基(N)和重要(V)。
市场占有率分析
市场占有率分析是一个综合工具,可以对智慧医疗产品市场供应商的现状进行深入而深入的研究。全面比较和分析供应商在整体收益、基本客群和其他关键指标方面的贡献,以便更好地了解公司的绩效及其在争夺市场占有率时面临的挑战。此外,该分析还提供了对该行业竞争特征的宝贵见解,包括在研究基准年观察到的累积、分散主导地位和合併特征等因素。详细程度的提高使供应商能够做出更明智的决策并制定有效的策略,从而在市场上获得竞争优势。
1. 市场渗透率:提供有关主要企业所服务的市场的全面资讯。
2. 市场开拓:我们深入研究利润丰厚的新兴市场,并分析其在成熟细分市场的渗透率。
3. 市场多元化:提供有关新产品发布、开拓地区、最新发展和投资的详细资讯。
4. 竞争评估和情报:对主要企业的市场占有率、策略、产品、认证、监管状况、专利状况和製造能力进行全面评估。
5. 产品开发与创新:提供对未来技术、研发活动和突破性产品开发的见解。
1. 智慧医疗市场规模及预测如何?
2.智慧医疗产品市场预测期间有哪些产品、细分市场、应用和领域值得考虑投资?
3. 智慧医疗市场的技术趋势和法规结构是什么?
4.智慧医疗市场主要厂商的市场占有率如何?
5. 进入智慧医疗市场的合适型态和策略手段是什么?
[189 Pages Report] The Smart Healthcare Products Market size was estimated at USD 7.69 billion in 2023 and expected to reach USD 8.92 billion in 2024, at a CAGR 16.11% to reach USD 21.91 billion by 2030.
The smart healthcare products market encompasses a range of products designed to improve patient care, enhance the efficiency of healthcare delivery, and optimize operational outcomes for healthcare providers. This market includes wearable devices, electronic health records, smart pills, and telemedicine solutions. Applications of smart healthcare products span various aspects of health management, including diagnosis, monitoring, treatment, health education, and wellness prevention. End-users cover a broad spectrum ranging from hospitals and clinics to individual consumers seeking personal health management solutions. This diverse application base highlights the market's expansive scope. The primary factors for the expansion of the smart healthcare products market include the rising prevalence of chronic diseases, aging populations, growing incidences of chronic diseases, higher penetration of smartphones, and the demand for personalized and efficient healthcare solutions. However, the market faces limitations such as high costs associated with smart healthcare products, data privacy and security problems, and a lack of standardization across platforms and devices. Regulatory challenges and the slow pace of technology adoption in certain regions also impede growth. On the other hand, growing government support for the digitization of healthcare infrastructure, introduction of advanced and innovative smart healthcare products, development of interoperable and scalable solutions that can seamlessly integrate into existing healthcare systems, providing real-time health monitoring and data analytics for predictive diagnostics and personalized treatment plans and focusing on innovations in data analytics, AI, and patient-centric models presents potential opportunities for the market to grow in the coming years.
KEY MARKET STATISTICS | |
---|---|
Base Year [2023] | USD 7.69 billion |
Estimated Year [2024] | USD 8.92 billion |
Forecast Year [2030] | USD 21.91 billion |
CAGR (%) | 16.11% |
Product Type: Increasing preference for mobile health (mHealth) products for personal health tracking
Electronic health record (EHR) systems are digital versions of patients' paper charts, accessible in real time. They contain the medical history, diagnoses, treatment plans, medications, immunization dates, allergies, radiology images, and laboratory test results of patients. EHR is preferred by healthcare providers for efficient, error-free documentation and easy access to patient data, facilitating better decision-making. Mobile health (mHealth) involves using mobile devices to track health parameters, manage diseases, and access healthcare services. This includes health monitoring apps, wellness apps, and medical consultation apps. mHealth is ideal for patients needing continuous monitoring, health-conscious individuals, and those requiring remote medical consultations. Smart pills are ingestible capsules equipped with electronic components to monitor health metrics or deliver drugs in a controlled manner. It is suitable for patients requiring stringent medication adherence and those undergoing complex treatments requiring close monitoring. Smart RFID cabinets are used to store and manage medications and supplies securely in healthcare facilities, automatically tracking inventory levels and usage. It is essential for hospitals and pharmacies needing to streamline inventory management, reduce theft, and ensure medication safety. Smart syringes are designed to prevent reuse, automatically disable after a single use, or feature needle retraction technology to avoid needlestick injuries. It is precious in preventing the spread of infectious diseases through needle sharing and accidental needlestick injuries in healthcare settings. Telemedicine allows patients to acquire healthcare services remotely through digital platforms, including video calls, enabling access to consultants and specialists without needing physical travel. Telemedicine is beneficial for patients in remote or underserved locations, those with mobility issues, or individuals seeking convenient access to specialist care. The smart healthcare products market is diverse, each segment addressing unique health needs. EHR and telemedicine emphasize data access and remote healthcare delivery, which are essential during and after the post-pandemic. mHealth offers personal health tracking, while smart pills and smart syringes focus on medication and treatment precision.
End-User: Expanding usage of smart healthcare products by hospitals to improve patient outcomes
Hospitals are prime users of smart healthcare products, focusing on improving patient outcomes, operational efficiency, and data-driven decision-making. High-demand hospital products include AI-enabled diagnostic and treatment systems, electronic health records (EHRs), smart beds, and patient monitoring systems. The key aspects hospitals look for in these innovations are interoperability, scalability, and the ability to integrate with existing hospital management systems. Ambulatory care units (ACUs) increasingly incorporate smart healthcare products to enhance patient care and operational efficiency. These units prefer compact, portable, and easy-to-use devices, given their often limited space and the need for mobility. Telehealth platforms, portable monitoring devices, and wearable health devices are in high demand in ACUs to facilitate remote patient monitoring and real-time health tracking. In-home care settings, there is a growing preference for smart healthcare products that support aging in place and manage chronic conditions. Devices that facilitate remote health monitoring, medication management, and emergency alert systems are particularly favored. Consumers in this segment prioritize ease of use, reliability, and integration capabilities with other smart home devices. When comparing the usage of smart healthcare products among ACUs, home care settings, and hospitals, several key differences emerge. ACUs and home care settings prioritize portability and ease of use, with a significant focus on remote monitoring capabilities to support patients outside traditional clinical environments. Conversely, hospitals emphasize sophisticated interoperability, data analytics, and AI-driven technologies to enhance patient care and hospital efficiency on a larger scale.
Regional Insights
In the United States and Canada, there is an increasing emphasis on healthcare efficiency and patient-centered care. The integration of the Internet of Things (IoT) in health devices, Artificial Intelligence (AI), and the presence of key market players have greatly influenced consumer needs and purchases. Chronic disease management and remote patient monitoring are high-priority areas, leading to the adoption of smart health wearables and telehealth solutions. South America is experiencing a rising adoption of smart healthcare products, especially in countries including Brazil, driven by an increasing understanding of the advantages of digital health technologies and telemedicine. With a heterogeneous landscape, the EMEA region presents diverse customer needs and purchasing behaviors. In EU countries, the focus is on digital health integration following regulatory frameworks, including the General Data Protection Regulation (GDPR), providing data privacy in digital health solutions. The Middle East, with a younger population, is keen on adopting innovative health technologies boosted by significant investments and government support. In Africa, despite infrastructural challenges, there is potential for mHealth solutions, mainly due to the high mobile penetration, and consumer needs are geared towards addressing health access issues and managing infectious diseases. The APAC region is expected to be a high-growth market for smart healthcare products due to the vast population base, rising disposable incomes, and increasing awareness of the potential of eHealth. Countries such as Japan, with its advanced technology sector, and China, with its large-scale manufacturing and adoption of digital technologies in healthcare, contribute significantly to this growth. India's market is burgeoning, focusing on affordable and accessible healthcare solutions facilitated by initiatives, including the Digital India program.
FPNV Positioning Matrix
The FPNV Positioning Matrix is pivotal in evaluating the Smart Healthcare Products Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Smart Healthcare Products Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Key Company Profiles
The report delves into recent significant developments in the Smart Healthcare Products Market, highlighting leading vendors and their innovative profiles. These include 3M Company, Abbott Laboratories, AirStrip Technologies, Inc., Allscripts Healthcare Solutions, Inc., American Well Corporation, Apple Inc., AT&T Inc., Becton, Dickinson and Company, CapsoVision, Inc., Cisco Systems Inc., eClinicalWorks, Epic Systems Corporation, General Electric Company, Gerresheimer AG, Honeywell International Inc., International Business Machines Corporation, Koninklijke Philips N.V., LifeSense Group, Logi-Tag Systems Ltd., McKesson Corporation, Medtronic PLC, Olympus Corporation, Oracle Corporation, Resideo Technologies, Inc., Samsung Electronics Co., Ltd., Securitas Healthcare LLC, Siemens AG, and Terumo Corporation.
Market Segmentation & Coverage
1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
1. What is the market size and forecast of the Smart Healthcare Products Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Smart Healthcare Products Market?
3. What are the technology trends and regulatory frameworks in the Smart Healthcare Products Market?
4. What is the market share of the leading vendors in the Smart Healthcare Products Market?
5. Which modes and strategic moves are suitable for entering the Smart Healthcare Products Market?